Article Details
Retrieved on: 2024-03-14 19:19:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma.
Article found on: jnm.snmjournals.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here